These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
315 related articles for article (PubMed ID: 21277920)
21. Doxorubicin derivative loaded acetal-PEG-PCCL micelles for overcoming multidrug resistance in MCF-7/ADR cells. Zhong XC; Xu WH; Wang ZT; Guo WW; Chen JJ; Guo NN; Wang TT; Lin MT; Zhang ZT; Lu YY; Yang QY; Han M; Xu DH; Gao JQ Drug Dev Ind Pharm; 2019 Sep; 45(9):1556-1564. PubMed ID: 31271317 [No Abstract] [Full Text] [Related]
22. Pegylated phosphotidylethanolamine inhibiting P-glycoprotein expression and enhancing retention of doxorubicin in MCF7/ADR cells. Wang J; Qu H; Jin L; Zeng W; Qin L; Zhang F; Wei X; Lu W; Zhang C; Liang W J Pharm Sci; 2011 Jun; 100(6):2267-77. PubMed ID: 21246559 [TBL] [Abstract][Full Text] [Related]
23. Indocyanine green/doxorubicin-encapsulated functionalized nanoparticles for effective combination therapy against human MDR breast cancer. Chen HH; Lu IL; Liu TI; Tsai YC; Chiang WH; Lin SC; Chiu HC Colloids Surf B Biointerfaces; 2019 May; 177():294-305. PubMed ID: 30771581 [TBL] [Abstract][Full Text] [Related]
24. Tumor-specific pH-responsive peptide-modified pH-sensitive liposomes containing doxorubicin for enhancing glioma targeting and anti-tumor activity. Zhao Y; Ren W; Zhong T; Zhang S; Huang D; Guo Y; Yao X; Wang C; Zhang WQ; Zhang X; Zhang Q J Control Release; 2016 Jan; 222():56-66. PubMed ID: 26682502 [TBL] [Abstract][Full Text] [Related]
25. A Dual Concentration-Tailored Cytokine-Chemo Nanosystem to Alleviate Multidrug Resistance and Redirect Balance of Cancer Proliferation and Apoptosis. Hsia Y; Sivasubramanian M; Chu CH; Chuang YC; Lai YK; Lo LW Int J Nanomedicine; 2023; 18():4253-4274. PubMed ID: 37534057 [TBL] [Abstract][Full Text] [Related]
26. Doxorubicin and indocyanine green loaded superparamagnetic iron oxide nanoparticles with PEGylated phospholipid coating for magnetic resonance with fluorescence imaging and chemotherapy of glioma. Shen C; Wang X; Zheng Z; Gao C; Chen X; Zhao S; Dai Z Int J Nanomedicine; 2019; 14():101-117. PubMed ID: 30587988 [TBL] [Abstract][Full Text] [Related]
27. Delivery of miR-375 and doxorubicin hydrochloride by lipid-coated hollow mesoporous silica nanoparticles to overcome multiple drug resistance in hepatocellular carcinoma. Xue H; Yu Z; Liu Y; Yuan W; Yang T; You J; He X; Lee RJ; Li L; Xu C Int J Nanomedicine; 2017; 12():5271-5287. PubMed ID: 28769563 [TBL] [Abstract][Full Text] [Related]
28. Doxorubicin-loaded iron oxide nanoparticles for glioblastoma therapy: a combinational approach for enhanced delivery of nanoparticles. Norouzi M; Yathindranath V; Thliveris JA; Kopec BM; Siahaan TJ; Miller DW Sci Rep; 2020 Jul; 10(1):11292. PubMed ID: 32647151 [TBL] [Abstract][Full Text] [Related]
29. pH-Dependent doxorubicin release from terpolymer of starch, polymethacrylic acid and polysorbate 80 nanoparticles for overcoming multi-drug resistance in human breast cancer cells. Shalviri A; Raval G; Prasad P; Chan C; Liu Q; Heerklotz H; Rauth AM; Wu XY Eur J Pharm Biopharm; 2012 Nov; 82(3):587-97. PubMed ID: 22995704 [TBL] [Abstract][Full Text] [Related]
30. Biotin-Conjugated Multilayer Poly [D,L-lactide-co-glycolide]-Lecithin-Polyethylene Glycol Nanoparticles for Targeted Delivery of Doxorubicin. Dai Y; Xing H; Song F; Yang Y; Qiu Z; Lu X; Liu Q; Ren S; Chen X; Li N J Pharm Sci; 2016 Sep; 105(9):2949-2958. PubMed ID: 27209461 [TBL] [Abstract][Full Text] [Related]
31. pH and redox dual-responsive nanoparticles based on disulfide-containing poly(β-amino ester) for combining chemotherapy and COX-2 inhibitor to overcome drug resistance in breast cancer. Zhang S; Guo N; Wan G; Zhang T; Li C; Wang Y; Wang Y; Liu Y J Nanobiotechnology; 2019 Oct; 17(1):109. PubMed ID: 31623608 [TBL] [Abstract][Full Text] [Related]
32. Comparative studies of polyethylenimine-doxorubicin conjugates with pH-sensitive and pH-insensitive linkers. Dong DW; Tong SW; Qi XR J Biomed Mater Res A; 2013 May; 101(5):1336-44. PubMed ID: 23065848 [TBL] [Abstract][Full Text] [Related]
34. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice. Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771 [TBL] [Abstract][Full Text] [Related]
35. Reversing multi-drug resistance by polymeric metformin to enhance antitumor efficacy of chemotherapy. Zhang H; Yu J; Ma L; Zhao Y; Xu S; Shi J; Qian K; Gu M; Tan H; Xu L; Liu Y; Mu C; Xiong Y Int J Pharm; 2022 Aug; 624():121931. PubMed ID: 35750278 [TBL] [Abstract][Full Text] [Related]
36. Towards the development of multifunctional chitosan-based iron oxide nanoparticles: Optimization and modelling of doxorubicin release. Soares PIP; Sousa AI; Ferreira IMM; Novo CMM; Borges JP Carbohydr Polym; 2016 Nov; 153():212-221. PubMed ID: 27561489 [TBL] [Abstract][Full Text] [Related]
37. Doxorubicin and siRNA Codelivery via Chitosan-Coated pH-Responsive Mixed Micellar Polyplexes for Enhanced Cancer Therapy in Multidrug-Resistant Tumors. Butt AM; Amin MC; Katas H; Abdul Murad NA; Jamal R; Kesharwani P Mol Pharm; 2016 Dec; 13(12):4179-4190. PubMed ID: 27934479 [TBL] [Abstract][Full Text] [Related]
38. Doxorubicin and adjudin co-loaded pH-sensitive nanoparticles for the treatment of drug-resistant cancer. Wang Q; Zou C; Wang L; Gao X; Wu J; Tan S; Wu G Acta Biomater; 2019 Aug; 94():469-481. PubMed ID: 31141733 [TBL] [Abstract][Full Text] [Related]
39. Dual-responsive mPEG-PLGA-PGlu hybrid-core nanoparticles with a high drug loading to reverse the multidrug resistance of breast cancer: an in vitro and in vivo evaluation. Xu H; Yang D; Cai C; Gou J; Zhang Y; Wang L; Zhong H; Tang X Acta Biomater; 2015 Apr; 16():156-68. PubMed ID: 25662165 [TBL] [Abstract][Full Text] [Related]
40. Improved cytotoxicity and preserved level of cell death induced in colon cancer cells by doxorubicin after its conjugation with iron-oxide magnetic nanoparticles. Augustin E; Czubek B; Nowicka AM; Kowalczyk A; Stojek Z; Mazerska Z Toxicol In Vitro; 2016 Jun; 33():45-53. PubMed ID: 26911730 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]